Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Hesperetin, a flavonoid found predominantly in citrus fruits, has garnered scientific interest for its potential neuroprotective properties, including possible relevance to Alzheimer’s Disease (AD). The use of hesperetin in the context of AD is not rooted in traditional medicine, but rather in preclinical studies that investigate its biological activities. Research, largely limited to in vitro studies and animal models, suggests hesperetin may exert beneficial effects by reducing oxidative stress, inhibiting neuroinflammation, and modulating amyloid-beta pathology—key mechanisms implicated in AD progression. For instance, several studies in rodent models have shown that hesperetin administration can attenuate cognitive deficits, decrease amyloid plaque burden, and lower markers of oxidative stress and inflammation in the brain. These effects are hypothesized to occur via modulation of pathways such as Nrf2/ARE and the inhibition of inflammatory cytokines.

However, it is important to note that, as of mid-2024, there is a lack of robust clinical trial evidence in humans to demonstrate efficacy or safety of hesperetin for the prevention or treatment of Alzheimer’s Disease. Most findings remain preliminary, and translation to human physiology is uncertain. While the mechanistic rationale is supported by laboratory data, further research, including well-designed clinical trials, is required before hesperetin can be recommended for AD management. Thus, while there is scientific rationale, the current level of evidence is modest.

More about hesperetin
More about Alzheimer's Disease

Other ingredients used for Alzheimer's Disease

Other health conditions supported by hesperetin

Products containing hesperetin